Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement onForm S-3 of our reports dated March 10, 2016, relating to the consolidated financial statements of Galena Biopharma, Inc. (the “Company”) and the effectiveness of the Company’s internal control over financial reporting appearing in the Company’s Annual Report in Amendment No. 2 to theForm 10-K for the year ended December 31, 2015, filed with the Securities and Exchange Commission.
/s/ Moss Adams LLP
Portland, Oregon
September 2, 2016